<prompt> Which of the following is a new drug recently approved for treatment of neovascular age related macular degeneration?BrolucizumabIstradefyllineLefamulinUpadacitinib  <response>: Brolucizumab is a monoclonal antibody against VEGF. It is recently approved for wet neovascular age related macular degeneration. Istradefylline is adenosine A2 receptor antagonist. It is approved for off episodes in Parkinsonism Lefamulin is a new antimicrobial that acts by inhibiting protein synthesis. It is approved for community acquired bacterial pneumonia. 